Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 4/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | EGFR | P00533 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.38 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.38 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL215965 | 1.00 | PTPN1 (0.58) | PTPN1ALOX15BLMLMNAALDH1A1 | |
| SCHEMBL997391 | 1.00 | PTPN1 (0.58) | PTPN1ALOX15BLMLMNAALDH1A1 | |
| SCHEMBL872939 | 1.00 | PTPN1 (0.58) | PTPN1ALOX15BLMLMNAALDH1A1 | |
| SCHEMBL3505233 | 1.00 | PTPN1 (0.58) | PTPN1ALOX15BLMLMNAALDH1A1 | |
| SCHEMBL14094312 | 0.92 | PTPN1 (0.58) | PTPN1ALOX15BLMLMNAALDH1A1 | |
| SCHEMBL16048661 | 0.92 | PTPN1 (0.58) | PTPN1ALOX15BLMLMNAALDH1A1 | |
| SCHEMBL31412851 | 0.89 | PTPN1 (0.55) | PTPN1ALOX15BLMLMNAALDH1A1 | |
| SCHEMBL16166818 | 0.89 | PTPN1 (0.55) | PTPN1ALOX15BLMLMNAALDH1A1 | |
| SCHEMBL25341538 | 0.88 | ALOX15 (0.61) | PTPN1ALOX15BLMLMNAALDH1A1 | |
| SCHEMBL7552905 | 0.87 | ALOX15 (0.70) | PTPN1ALOX15LMNAALDH1A1CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110015397-A1 | Selective Aliphatic C-H Oxidation | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2011-01-20 | — | — | US | disclosed |
| US-7829342-B2 | composition including a complex of a metal, a tetradentate ligand, at least one ancillary ligand, and a counterion is used for selective sp3 C H bond oxidation; includes a N-heterocyclic-N,N'-bis(pyridyl)-ethane-1,2-diamine group or a N,N'-bis(heterocyclic)-N,N'-bis(pyridyl)-ethane-1,2-diamine group | THE BOARD OF TRUSTEES OF THE UNIVERSIY OF ILLINOIS (US) | 2010-11-09 | — | — | US | disclosed |
| US-7825149-B2 | Substituted imidazoles | PFIZER LIMITED (GB) | 2010-11-02 | — | — | US | disclosed |
| US-20090312326-A1 | SUBSTITUTED IMIDAZOLES | PFIZER LIMITED (GB) | 2009-12-17 | — | — | US | disclosed |
| US-7592362-B2 | Substituted imidazoles | PFIZER LIMITED (GB) | 2009-09-22 | — | — | US | disclosed |
| US-20090221083-A1 | Selective Aliphatic C-H Oxidation | BOARD OF TRUSTEES OF UNIVERSITY OF ILLINOIS (US) | 2009-09-03 | — | — | US | disclosed |
| US-7547718-B2 | Substituted imidazoles | PFIZER LIMITED (GB) | 2009-06-16 | — | — | US | disclosed |
| US-7544706-B2 | Substituted imidazoles | PFIZER LIMITED (GB) | 2009-06-09 | — | — | US | disclosed |
| US-20080125473-A1 | SUBSTITUTED IMIDAZOLES | PFIZER LIMITED (GB) | 2008-05-29 | — | — | US | disclosed |
| US-20080119536-A1 | SUBSTITUTED IMIDAZOLES | PFIZER LIMITED (GB) | 2008-05-22 | — | — | US | disclosed |
| US-20070167506-A1 | SUBSTITUTED IMIDAZOLES | PFIZER INC. (US) | 2007-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080125473-A1 | SUBSTITUTED IMIDAZOLES | ABL1, TYR, CYP3A4 | PTPN1 3756/4885ALOX15 4647/4885BLM 1994/4885 |
| US-20110015397-A1 | Selective Aliphatic C-H Oxidation | AOC3, SOD3, AP3S1 | PTPN1 1257/4885ALOX15 2139/4885BLM 3998/4885 |
| US-20090221083-A1 | Selective Aliphatic C-H Oxidation | AOC3, SOD3, AP3S1 | PTPN1 1257/4885ALOX15 2139/4885BLM 3998/4885 |
| US-20090312326-A1 | SUBSTITUTED IMIDAZOLES | ABL1, TYR, CYP3A4 | PTPN1 3756/4885ALOX15 4647/4885BLM 1994/4885 |
| US-20070167506-A1 | SUBSTITUTED IMIDAZOLES | ABL1, TYR, CYP3A4 | PTPN1 3756/4885ALOX15 4647/4885BLM 1994/4885 |
| US-20080119536-A1 | SUBSTITUTED IMIDAZOLES | ABL1, TYR, CYP3A4 | PTPN1 3756/4885ALOX15 4647/4885BLM 1994/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.